Additionally, the higher GLP-1 levels associated with these specialized formulas may further facilitate the reducing of postprandial BG levels, indicating their superiority in managing diabetes compared to SFs or MUFA-rich low-carbohydrate formulas [32]. The gene discussed is GCG; the disease is diabetes mellitus.